← Back to TMCI

Treace Medical Concepts, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 07/08/2026Dec 2025Filed 06/04/2026Sep 2025Filed 06/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 07/08/2026Dec 2024Filed 06/04/2026Sep 2024Filed 06/11/2025
$45$47$50$47$53$45
−$16−$18−$9.4−$16−$17−$16−$0.5−$15
−$0.24−$0.28−$0.26−$0.28−$0.25−$0.25
656564636362

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.